[HTML][HTML] Evaluating human papillomavirus vaccination programs
AV Taira, CP Neukermans… - Emerging infectious …, 2004 - ncbi.nlm.nih.gov
Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
Evaluating Human Papillomavirus Vaccination Programs.
AV Taira, CP Neukermans… - Emerging Infectious …, 2004 - search.ebscohost.com
Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
Evaluating Human Papillomavirus Vaccination Programs
AV Taira, CP Neukermans, GD Sanders - 2004 - stacks.cdc.gov
Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
Evaluating human papillomavirus vaccination programs
AV Taira, CP Neukermans… - Emerging infectious …, 2004 - pubmed.ncbi.nlm.nih.gov
Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
Evaluating human papillomavirus vaccination programs.
AV Taira, CP Neukermans, GD Sanders - 2004 - cabidigitallibrary.org
Human papillomavirus (HPV) has been implicated as the primary aetiological agent of
cervical cancer. Potential vaccines against high-risk HPV types are in clinical trials. We …
cervical cancer. Potential vaccines against high-risk HPV types are in clinical trials. We …
Evaluating human papillomavirus vaccination programs.
AV Taira, CP Neukermans… - Emerging Infectious …, 2004 - europepmc.org
Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
[PDF][PDF] Evaluating Human Papillomavirus Vaccination Programs
AV Taira, CP Neukermans, GD Sanders - Citeseer
Methods To capture the effect of a male vaccination program on female HPV infection rates
and cervical cancer incidence, we needed to directly model the effect of vaccination on HPV …
and cervical cancer incidence, we needed to directly model the effect of vaccination on HPV …
[PDF][PDF] Evaluating Human Papillomavirus Vaccination Programs
AV Taira, CP Neukermans, GD Sanders - pdfs.semanticscholar.org
Methods To capture the effect of a male vaccination program on female HPV infection rates
and cervical cancer incidence, we needed to directly model the effect of vaccination on HPV …
and cervical cancer incidence, we needed to directly model the effect of vaccination on HPV …
Evaluating human papillomavirus vaccination programs
AV Taira, CP Neukermans, GD Sanders - Emerging Infectious …, 2004 - go.gale.com
Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
Evaluating Human Papillomavirus Vaccination Programs.
AV Taira, CP Neukermans… - Emerging Infectious …, 2004 - search.ebscohost.com
Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …